ClinicalTrialStartPulse: Phase 2
1,114 clinicalTrialStartPulse: Phase 2 are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-09-14 to 2026-11-03; the most frequent is National Cancer Institute (NCI) with 17. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
1,114 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are listed here), dated 2026-09-14 to 2026-11-03. Most frequent: National Cancer Institute (NCI) (17). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Get new ClinicalTrialStartPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- National Cancer Institute (NCI) (17)
- Janssen Research & Development, LLC (13)
- AstraZeneca (12)
- Merck Sharp & Dohme LLC (11)
- Pfizer (10)
How do I get new clinicalTrialStartPulse: Phase 2 by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top clinicalTrialStartPulse: Phase 2 right now?
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| Nurix Therapeutics, Inc. | Phase 2 | B-cell Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma | 150 |
| Janssen Research & Development, LLC | Phase 2 | Leukemia, Lymphocytic, Chronic, B-Cell; Small Lymphocytic Lymphoma | 333 |
| Janssen Research & Development, LLC | Phase 2 | Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse | 166 |
| Janssen Research & Development, LLC | Phase 2 | Carcinoma, Non-Small-Cell Lung | 305 |
| Janssen Research & Development, LLC | Phase 2 | Multiple Myeloma | 168 |
| Teva Branded Pharmaceutical Products R&D LLC | Phase 2 | Multiple System Atrophy | 349 |
| Genmab | Phase 2 | Diffuse Large B-Cell Lymphoma; Follicular Lymphoma | 543 |
| Janssen Research & Development, LLC | Phase 2 | Multiple Myeloma | 208 |
| Janssen Research & Development, LLC | Phase 2 | Non-Muscle Invasive Bladder Neoplasms | 235 |
| Apogee Therapeutics, Inc. | Phase 2 | Atopic Dermatitis | 470 |
| Janssen Research & Development, LLC | Phase 2 | Dermatitis, Atopic | 189 |
| BeOne Medicines | Phase 2 | Hepatocellular Cancer; Liver Cancer; Hepatocellular Carcinoma | 100 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 2 | Advanced Solid Tumors | 154 |
| InnovStone Therapeutics Limited | Phase 2 | Uncontrolled Hypertension; Resistant Hypertension | 264 |
| Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | Phase 2 | Hyperlipoproteinemia (a) | 192 |
| Janssen Research & Development, LLC | 🔒 Unlock all 500 records → | ||
| Takeda | 🔒 Unlock all 500 records → | ||
| Janssen Research & Development, LLC | 🔒 Unlock all 500 records → | ||
Browse 35 more matching record reports
- Janssen Research & Development, LLC
- Takeda
- Janssen Research & Development, LLC
- Hoffmann-La Roche
- Sanofi
- Merck Sharp & Dohme LLC
- Xilio Development, Inc.
- AstraZeneca
- Sanofi
- AstraZeneca
- Innovent Biologics (Suzhou) Co. Ltd.
- Pfizer
- Hoffmann-La Roche
- Pelage Pharmaceuticals, Inc.
- 35Pharma Inc., a GSK company
- BeiGene
- atai Therapeutics, Inc.
- AbbVie
- AstraZeneca
- NS Pharma, Inc.
- AstraZeneca
- Carmot Therapeutics, Inc.
- Paulex Bio Inc.
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Beijing InnoCare Pharma Tech Co., Ltd.
- CytomX Therapeutics
- NS Pharma, Inc.
- Uniquity One (UNI)
- AbbVie
- Takeda
- Uniquity One (UNI)
- Grand Theravac Life Sciences (Hangzhou) Co., Ltd.
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Tango Therapeutics, Inc.
- Invivyd, Inc.
More records in this hub: page 2 · page 3 · page 4
Browse all ClinicalTrialStartPulse record reports
Which related categories and locations should I check?
Browse by phase
Not applicable (device, behavioral) (4369) Observational (2063) Phase 3 (576) Phase 1 (570) Phase 4 (332) Early phase 1 (91)
Browse by site location
Outside the US only (6603) United States sites (2512)
Browse by minimum enrollment
100+ (336) 50+ (291) 300+ (99) 1,000+ (58)
Frequently asked questions
How many clinicalTrialStartPulse: Phase 2 are listed?
1,114 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (the 500 newest are shown on this page), last refreshed automatically. The most recent is dated 2026-11-03.
Can I get alerts for Phase 2?
Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page.
Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. RSS feed of new records